Thrombosis Risk in Cancer Patients Receiving Red Blood Cell Transfusions

Abstract

Patients with cancer have increased risk of thrombosis and often need red blood cell (RBC) transfusions. However, RBC transfusions may also promote thrombosis because of raised hematocrit and viscosity, storage-related RBC damage, and exposure to thrombogenic mediators from obsolescent RBCs. The authors conducted a literature survey for studies examining whether RBC transfusions were associated with increased risk of venous thromboembolism (VTE) in cancer patients. In perioperative cancer surgery patients with categorical comparisons of any versus no RBC transfusion, increased risk of VTE with RBC transfusion was found in 11 of 31 studies, 5 by univariate correlation only and 6 in multivariate analysis. All six multivariate-positive studies had intermediate overall rates of thrombosis (1.4–6.0%), and three were in urological surgery series. In the larger studies of > 2,000 patients (range: 2,219–44,656), the maximum odds ratio among the multivariate-positive studies was 1.3. Perioperative RBC transfusion volume was more strongly associated with VTE risk, with a positive association in six of seven studies. One large registry-based study of hospitalized cancer patients, not restricted to the perioperative setting, found an adjusted odds ratio of 1.60 (95% confidence interval: 1.53–1.67) for VTE risk in patients receiving RBCs compared with nontransfused patients.

Keywords

cancer - red blood cell transfusion - postoperative complications - venous thromboembolism

• References

• 1 Weisel JW, Litvinov RI. Red blood cells: the forgotten player in hemostasis and thrombosis. J Thromb Haemost 2019; 17 (02) 271-282
• 2 Kroll MH, Michaelis LC, Verstovsek S. Mechanisms of thrombogenesis in polycythemia vera. Blood Rev 2015; 29 (04) 215-221
• 3 Barshtein G, Ben-Ami R, Yedgar S. Role of red blood cell flow behavior in hemodynamics and hemostasis. Expert Rev Cardiovasc Ther 2007; 5 (04) 743-752
• 4 Begg TB, Hearns JB. Components in blood viscosity. The relative contribution of haematocrit, plasma fibrinogen and other proteins. Clin Sci 1966; 31 (01) 87-93
• 5 Kwaan HC, Wang J. Hyperviscosity in polycythemia vera and other red cell abnormalities. Semin Thromb Hemost 2003; 29 (05) 451-458
• 6 Turitto VT, Baumgartner HR. Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells. Microvasc Res 1975; 9 (03) 335-344
• 7 Chen H, Angerer JI, Napoleone M. , et al. Hematocrit and flow rate regulate the adhesion of platelets to von Willebrand factor. Biomicrofluidics 2013; 7 (06) 64113
• 8 Du VX, Huskens D, Maas C, Al Dieri R, de Groot PG, de Laat B. New insights into the role of erythrocytes in thrombus formation. Semin Thromb Hemost 2014; 40 (01) 72-80
• 9 Becatti M, Marcucci R, Gori AM. , et al. Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion. J Thromb Haemost 2016; 14 (11) 2287-2297
• 10 Dubovoy T, Engoren M. Thrombotic risks in red blood cell transfusions. Semin Thromb Hemost 2016; 42 (02) 102-111
• 11 Lominadze D, Dean WL. Involvement of fibrinogen specific binding in erythrocyte aggregation. FEBS Lett 2002; 517 (1–3): 41-44
• 12 Byrnes JR, Duval C, Wang Y. , et al. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. Blood 2015; 126 (16) 1940-1948
• 13 Wohner N, Sótonyi P, Machovich R. , et al. Lytic resistance of fibrin containing red blood cells. Arterioscler Thromb Vasc Biol 2011; 31 (10) 2306-2313
• 14 Bosman GJ, Werre JM, Willekens FLA, Novotný VM. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008; 18 (06) 335-347
• 15 Chin-Yee I, Arya N, d'Almeida MS. The red cell storage lesion and its implication for transfusion. Transfus Sci 1997; 18 (03) 447-458
• 16 Rubin O, Crettaz D, Tissot JD, Lion N. Microparticles in stored red blood cells: submicron clotting bombs?. Blood Transfus 2010; 8 (Suppl. 03) s31-s38
• 17 Gao Y, Lv L, Liu S, Ma G, Su Y. Elevated levels of thrombin-generating microparticles in stored red blood cells. Vox Sang 2013; 105 (01) 11-17
• 18 Donadee C, Raat NJ, Kanias T. , et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124 (04) 465-476
• 19 Keating FK, Butenas S, Fung MK, Schneider DJ. Platelet-white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells. Transfusion 2011; 51 (05) 1086-1095
• 20 Wautier MP, Héron E, Picot J, Colin Y, Hermine O, Wautier JL. Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion. J Thromb Haemost 2011; 9 (05) 1049-1055
• 21 Wautier JL, Wautier MP. Molecular basis of erythrocyte adhesion to endothelial cells in diseases. Clin Hemorheol Microcirc 2013; 53 (1,2): 11-21
• 22 Mertens K, Bertina RM. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX. Biochem J 1984; 223 (03) 607-615
• 23 Biró E, Sturk-Maquelin KN, Vogel GMT. , et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 1 (12) 2561-2568
• 24 Goel R, Patel EU, Cushing MM. , et al. Association of perioperative red blood cell transfusions with venous thromboembolism in a North American registry. JAMA Surg 2018; 153 (09) 826-833
• 25 Thai L, McCarn K, Stott W. , et al. Venous thromboembolism in patients with head and neck cancer after surgery. Head Neck 2013; 35 (01) 4-9
• 26 Lee HK, Kim DH, Jin US, Jeon YT, Hwang JW, Park HP. Effect of perioperative transfusion of old red blood cells on postoperative complications after free muscle sparing transverse rectus abdominis myocutaneous flap surgery for breast reconstruction. Microsurgery 2014; 34 (06) 434-438
• 27 Sultan SM, Jackson DS, Erhard HA. , et al. Risk factors for postoperative venous thromboembolic complications after microsurgical breast reconstruction. J Reconstr Microsurg 2018; 34 (04) 227-234
• 28 Martin JT, Mahan AL, Ferraris VA. , et al. Identifying esophagectomy patients at risk for predischarge versus postdischarge venous thromboembolism. Ann Thorac Surg 2015; 100 (03) 932-938 , discussion 938
• 29 Ejaz A, Spolverato G, Kim Y. , et al. Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg 2014; 18 (06) 1116-1124
• 30 Newhook TE, LaPar DJ, Walters DM. , et al. Impact of postoperative venous thromboembolism on postoperative morbidity, mortality, and resource utilization after hepatectomy. Am Surg 2015; 81 (12) 1216-1223
• 31 Lee FY, Chu W, Chan R. , et al. Incidence of deep vein thrombosis after colorectal surgery in a Chinese population. ANZ J Surg 2001; 71 (11) 637-640
• 32 Nilsson KR, Berenholtz SM, Garrett-Mayer E, Dorman T, Klag MJ, Pronovost PJ. Association between venous thromboembolism and perioperative allogeneic transfusion. Arch Surg 2007; 142 (02) 126-132 , discussion 133
• 33 Xenos ES, Vargas HD, Davenport DL. Association of blood transfusion and venous thromboembolism after colorectal cancer resection. Thromb Res 2012; 129 (05) 568-572
• 34 Davenport DL, Vargas HD, Kasten MW, Xenos ES. Timing and perioperative risk factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer resection. Clin Appl Thromb Hemost 2012; 18 (06) 569-575
• 35 Rottenstreich A, Kalish Y, Kleinstern G, Yaacov AB, Dux J, Nissan A. Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 2017; 116 (07) 914-920
• 36 Sugimachi K, Tajiri H, Kinjo N. , et al. Incidence and predictors of deep venous thrombosis after abdominal oncologic surgery: prospective Doppler ultrasound screening. J Surg Res 2012; 178 (02) 657-661
• 37 Bellini G, Teng A, Kotecha N. , et al. The identification of risk factors for venous thromboembolism in gastrointestinal oncologic surgery. J Surg Res 2016; 205 (02) 279-285
• 38 Secin FP, Jiborn T, Bjartell AS. , et al. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy. Eur Urol 2008; 53 (01) 134-145
• 39 Beyer J, Wessela S, Hakenberg OW. , et al. Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery. J Thromb Haemost 2009; 7 (04) 597-604
• 40 Tollefson MK, Karnes RJ, Rangel L, Carlson R, Boorjian SA. Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy. J Urol 2014; 191 (03) 646-651
• 41 Abel EJ, Wong K, Sado M. , et al. Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. JSLS 2014; 18 (02) 282-287
• 42 Alberts BD, Woldu SL, Weinberg AC, Danzig MR, Korets R, Badani KK. Venous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operations. Urology 2014; 84 (04) 799-806
• 43 Chen EC, Papa N, Lawrentschuk N, Bolton D, Sengupta S. Incidence and risk factors of venous thromboembolism after pelvic uro-oncologic surgery--a single center experience. BJU Int 2016; 117 (Suppl. 04) 50-53
• 44 Lee SJ, Seo H, Kim H-C. , et al. Effect of intraoperative red blood cell transfusion on postoperative complications after open radical cystectomy: old versus fresh stored blood. Clin Genitourin Cancer 2015; 13 (06) 581-587
• 45 Chappidi MR, Chalfin HJ, Johnson DJ. , et al. Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy. Urol Oncol 2017; 35 (02) 38.e17-38.e24
• 46 Lyon TD, Tollefson MK, Shah PH. , et al. Temporal trends in venous thromboembolism after radical cystectomy. Urol Oncol 2018; 36 (08) 361.e15-361.e21
• 47 Bhanvadia S, Kazerouni K, Bazargani ST. , et al. Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy. World J Urol 2019; 37 (01) 173-179
• 48 Yoo S, Song SH, Go H. , et al. Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus. Int Urol Nephrol 2017; 49 (07) 1157-1163
• 49 Clément C, Rossi P, Aissi K. , et al. Incidence, risk profile and morphological pattern of lower extremity venous thromboembolism after urological cancer surgery. J Urol 2011; 186 (06) 2293-2297
• 50 Abu-Rustum NR, Richard S, Wilton A. , et al. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival. Gynecol Oncol 2005; 99 (02) 320-326
• 51 Sandadi S, Lee S, Walter A. , et al. Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer. Obstet Gynecol 2012; 120 (05) 1077-1083
• 52 Freeman AH, Barrie A, Lyon L. , et al. Venous thromboembolism following minimally invasive surgery among women with endometrial cancer. Gynecol Oncol 2016; 142 (02) 267-272
• 53 Mahdi H, Aljebori Q, Lockart D, Moulton L. Risk of venous thromboembolism after laparoscopic surgery for gynecologic malignancy. J Minim Invasive Gynecol 2016; 23 (07) 1057-1062
• 54 Merkow RP, Bilimoria KY, McCarter MD. , et al. Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg 2011; 254 (01) 131-137
• 55 De Martino RR, Goodney PP, Spangler EL. , et al. Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg 2012; 55 (04) 1035-1040.e4
• 56 de Almeida JP, Vincent JL, Galas FR. , et al. Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology 2015; 122 (01) 29-38
• 57 Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008; 168 (21) 2377-2381
• 58 Li M, Guo Q, Hu W. Incidence, risk factors, and outcomes of venous thromboembolism after oncologic surgery: A systematic review and meta-analysis. Thromb Res 2019; 173: 48-56
• 59 Marušič AP, Locatelli I, Mrhar A. , et al. Influence of prescribed blood products on the incidence of deep vein thrombosis and pulmonary embolism in surgical patients. Clin Appl Thromb Hemost 2017; 23 (08) 938-942
• 60 Patel MS, Ewing T, Kong A. , et al. Risk factors for venous thromboembolism in critically ill nontrauma surgical patients who cannot receive chemical prophylaxis. Am J Surg 2013; 206 (03) 300-306
• 61 Cloney M, Dhillon ES, Roberts H, Smith ZA, Koski TR, Dahdaleh NS. Predictors of readmissions and reoperations related to venous thromboembolic events after spine surgery: a single-institution experience with 6869 patients. World Neurosurg 2018; 111: e91-e97
• 62 Kumar MA, Boland TA, Baiou M. , et al. Red blood cell transfusion increases the risk of thrombotic events in patients with subarachnoid hemorrhage. Neurocrit Care 2014; 20 (01) 84-90
• 63 Thurn L, Wikman A, Lindqvist PG. Postpartum blood transfusion and hemorrhage as independent risk factors for venous thromboembolism. Thromb Res 2018; 165: 54-60
• 64 Dhillon NK, Smith EJT, Ko A. , et al. The risk factors of venous thromboembolism in massively transfused patients. J Surg Res 2018; 222: 115-121
• 65 Hershman DL, Buono DL, Malin J, McBride R, Tsai WY, Neugut AI. Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer. J Natl Cancer Inst 2009; 101 (23) 1633-1641
• 66 Desborough MJR, Colman KS, Prick BW. , et al. Effect of restrictive versus liberal red cell transfusion strategies on haemostasis: systematic review and meta-analysis. Thromb Haemost 2017; 117 (05) 889-898
• 67 Robitaille N, Lacroix J, Alexandrov L. , et al. Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a canadian blood and marrow transplant group trial. Biol Blood Marrow Transplant 2013; 19 (03) 468-473
• 68 Rogers MAM, Blumberg N, Bernstein SJ, Flanders SA, Chopra V. Association between delivery methods for red blood cell transfusion and the risk of venous thromboembolism: a longitudinal study. Lancet Haematol 2016; 3 (12) e563-e571
• 69 Zander AL, Olson EJ, Van Gent JM. , et al. Does resuscitation with plasma increase the risk of venous thromboembolism?. J Trauma Acute Care Surg 2015; 78 (01) 39-43 , discussion 43–44
• 70 Schmidt AE, Refaai MA, Blumberg N. Platelet transfusion and thrombosis: more questions than answers. Semin Thromb Hemost 2016; 42 (02) 118-124
• 71 Schmidt AE, Henrichs KF, Kirkley SA, Refaai MA, Blumberg N. Prophylactic preprocedure platelet transfusion is associated with increased risk of thrombosis and mortality. Am J Clin Pathol 2017; 149 (01) 87-94